This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;78(1):35-7.

doi: 10.1111/j.1399-0004.2010.01414_3.x.

Down's syndrome patients are less likely to develop cancer

K A Pussegoda¹

Affiliations

Affiliation

¹ Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Vancouver, BC, Canada. kusala@cmmt.ubc.ca

PMID: 20597922
DOI: 10.1111/j.1399-0004.2010.01414_3.x

Comment

Down's syndrome patients are less likely to develop cancer

K A Pussegoda. Clin Genet. 2010 Jul.

. 2010 Jul;78(1):35-7.

doi: 10.1111/j.1399-0004.2010.01414_3.x.

Author

K A Pussegoda¹

Affiliation

¹ Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Vancouver, BC, Canada. kusala@cmmt.ubc.ca

PMID: 20597922
DOI: 10.1111/j.1399-0004.2010.01414_3.x

No abstract available

PubMed Disclaimer

Comment in

Down syndrome patients are less likely to develop some (but not all) malignant solid tumours.
Satgé D, Vekemans M. Satgé D, et al. Clin Genet. 2011 Mar;79(3):289-90; author reply 291-2. doi: 10.1111/j.1399-0004.2010.01521.x. Clin Genet. 2011. PMID: 21294716 No abstract available.

Comment on

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S. Baek KH, et al. Nature. 2009 Jun 25;459(7250):1126-30. doi: 10.1038/nature08062. Epub 2009 May 20. Nature. 2009. PMID: 19458618 Free PMC article.

Similar articles

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL. Rumble B, et al. N Engl J Med. 1989 Jun 1;320(22):1446-52. doi: 10.1056/NEJM198906013202203. N Engl J Med. 1989. PMID: 2566117
Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease.
Clapp S, Perry BL, Farooki ZQ, Jackson WL, Karpawich PP, Hakimi M, Arciniegas E, Green EW, Pinsky WW. Clapp S, et al. J Thorac Cardiovasc Surg. 1990 Jul;100(1):115-21. J Thorac Cardiovasc Surg. 1990. PMID: 2142250
Islet autoimmunity in children with Down's syndrome.
Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Gillespie KM, et al. Diabetes. 2006 Nov;55(11):3185-8. doi: 10.2337/db06-0856. Diabetes. 2006. PMID: 17065360
Association of Down's syndrome and testicular cancer.
Dieckmann KP, Rübe C, Henke RP. Dieckmann KP, et al. J Urol. 1997 May;157(5):1701-4. J Urol. 1997. PMID: 9112509 Review.
Maternal serum markers for Down's syndrome pregnancies.
Chew S, Anandakumar C, Ratnam SS. Chew S, et al. Singapore Med J. 1995 Aug;36(4):417-23. Singapore Med J. 1995. PMID: 8919160 Review.

See all similar articles

Cited by

Glutamate receptor ionotropic, kainate 1 serves as a novel tumor suppressor of colorectal carcinoma and predicts clinical prognosis.
Ren Z, Liu J, Yao L, Li J, Qi Z, Li B. Ren Z, et al. Exp Ther Med. 2020 Dec;20(6):167. doi: 10.3892/etm.2020.9296. Epub 2020 Oct 9. Exp Ther Med. 2020. PMID: 33093905 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley